Emulsion compositions and methods of their use

US11274337B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11274337-B2
Application numberUS-202016921453-A
CountryUS
Kind codeB2
Filing dateJul 6, 2020
Priority dateJan 30, 2017
Publication dateMar 15, 2022
Grant dateMar 15, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Emulsion compositions are provided herein. Also provided herein are kits containing one or more emulsion compositions or components for making such emulsion compositions. Also provided herein are methods of using such emulsion compositions, such as for amplification of target nucleic acids in emulsion droplets.

First claim

Opening claim text (preview).

What is claimed is: 1. An emulsion comprising a water-in-oil emulsion droplets, the droplets comprising: water; a plurality of cyclodextrin molecules; and a plurality of amphiphilic polymer molecules, wherein individual amphiphilic polymer molecules of the plurality comprise a hydrophobic moiety and a hydrophilic moiety, wherein at least a portion of the cyclodextrin molecules and the amphiphilic polymer molecules form a thermally-reversible hydrogel that is in sol form at at least one temperature between 0-70° C., wherein the thermally-reversible hydrogel comprises a plurality of polypseudorotaxane complexes, wherein a mass ratio of cyclodextrin molecules to amphiphilic polymer molecules in the droplets is from about 1:4 to about 4:1, and wherein the droplets are present in a continuous oil phase. 2. The emulsion of claim 1 , wherein individual cyclodextrin molecules of the plurality are independently selected from the group consisting of: an α-cyclodextrin, and a β-cyclodextrin; or an α-cyclodextrin, and a γ-cyclodextrin; or a β-cyclodextrin, and a γ-cyclodextrin. 3. The emulsion of claim 1 , wherein individual cyclodextrin molecules of the plurality are independently a compound of Formula I: wherein: each R1 is independently selected from the group consisting of a hydrophobic group, a sulfite, and H, where the hydrophobic group is selected from alkyl, alkenyl, alkynyl, haloalkyl, cycloalkyl, aryl, and any combination thereof, and the sulfite is a (C1-C6-alkyl or alkylene)-SO3-group; and n is 6, 7, or 8. 4. The emulsion of claim 1 , wherein the amphiphilic polymer molecules comprise block co-polymers, wherein the block co-polymers comprise a hydrophilic block and a hydrophobic block. 5. The emulsion of claim 4 , wherein the block co-polymers are di-block co-polymers or tri-block co-polymers, or a combination thereof. 6. The emulsion of claim 5 , wherein the block co-polymers are di-block co-polymers comprising a polyethylene glycol (PEG) hydrophilic block and a hydrophobic block. 7. The emulsion of claim 5 , wherein the block co-polymers are di-block co-polymers comprising a hydrophilic block and a hydrophobic block comprising polypropylene glycol. 8. The emulsion of claim 5 , wherein the block co-polymers are tri-block co-polymers. 9. The emulsion of claim 8 , wherein the tri-block co-polymers are poloxamers. 10. The emulsion of claim 9 , wherein the poloxamers are poloxamer 188. 11. The emulsion of claim 1 , wherein the droplets further comprise a thermostable DNA-dependent DNA polymerase or an RNA-dependent DNA polymerase. 12. The emulsion of claim 1 , wherein the droplets further comprise nucleic acid. 13. The emulsion of claim 1 , wherein the droplets comprise a thermally reversible hydrogel. 14. The emulsion of claim 1 , wherein the droplets are present in a continuous fluorocarbon oil phase. 15. The emulsion of claim 14 , wherein the continuous fluorocarbon oil phase comprises a fluorous oil and a surfactant. 16. The emulsion of claim 15 , wherein the surfactant is a fluorosurfactant. 17. The emulsion of claim 16 , wherein the fluorosurfactant is a block co-polymer comprising a perfluorinated polyether block and a polyethylene glycol block. 18. A method of forming an emulsion according to claim 1 , the method comprising: combining a continuous oil phase, an aqueous solution, a plurality of cyclodextrin molecules, and a plurality of amphiphilic polymer molecules, under conditions wherein at least a portion of the cyclodextrin molecules and the amphiphilic polymer molecules form a plurality of polypseudorotaxane complexes, thereby forming an emulsion comprising a water-in-oil emulsion droplets. 19. A method of using an emulsion comprising a water-in-oil emulsion droplets, the method comprising: providing the emulsion according to claim 1 ; heating the droplets to a temperature of between about 50° C. to about 100° C.; cooling the droplets to a temperature below about 50° C.; and optionally repeating the heating and cooling between 1-50 times.

Assignees

Inventors

Classifications

  • C12Q1/6846Primary

    Common amplification features · CPC title

  • Specific component of sample, medium or buffer · CPC title

  • C12Q1/6848Primary

    characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction · CPC title

  • characterised by the detection means (C12Q1/6804 takes precedence) · CPC title

  • Polymerase chain reaction [PCR] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11274337B2 cover?
Emulsion compositions are provided herein. Also provided herein are kits containing one or more emulsion compositions or components for making such emulsion compositions. Also provided herein are methods of using such emulsion compositions, such as for amplification of target nucleic acids in emulsion droplets.
Who is the assignee on this patent?
Bio Rad Laboratories
What technology area does this patent fall under?
Primary CPC classification C12Q1/6846. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).